Literature DB >> 30976936

Lipid-Coated, pH-Sensitive Magnesium Phosphate Particles for Intracellular Protein Delivery.

Yunzhou Fang1, Mallika Vadlamudi1, Yingbo Huang1, Xin Guo2.   

Abstract

PURPOSE: To develop cationic lipid-coated magnesium phosphate nanoparticles (LPP) for intracellular catalase (CAT) delivery.
METHODS: Magnesium phosphate nanoparticles (MgP NP) were prepared by micro-emulsion precipitation and mixed with catalase-loaded cationic liposomes (DOTAP/cholesterol) to yield LPP formulation of catalase (LPP-CAT). The size and ζ-potential of LPP-CAT were measured by dynamic light scattering. The pH-sensitivity of LPP-CAT was determined by monitoring their degradation of hydrogen peroxide (H2O2) and their morphologies under transmission electron microscopy (TEM) at pH 7.4 and 5.5. The ability of LPP-CAT to protect MCF-7 cells against hydrogen peroxide was measured by MTS assay. ROS levels in EA.hy926 cells were measured after treatment with LPP-CAT.
RESULTS: LPP-CAT were successfully prepared and carried an average diameter of <300 nm and ζ -potential of about +40 mV. At pH 5.5, LPP-CAT degraded H2O2 almost 4-fold as fast as pH 7.4 and displayed drastic morphological changes of an osmotic explosion. LPP-CAT protected MCF-7 cells from lethal level of exogenous H2O2 and significantly lowered the ROS levels in EA.hy926 cells. A lipid with a pH-sensitive conformational switch (flipid) further enhanced the protein delivery of LPP-CAT.
CONCLUSION: LPP represents a promising nano-system for intracellular protein delivery.

Entities:  

Keywords:  intracellular delivery; liposome; magnesium phosphate nanoparticles; protein delivery; triggered release

Mesh:

Substances:

Year:  2019        PMID: 30976936     DOI: 10.1007/s11095-019-2607-6

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  2 in total

Review 1.  Therapeutic lipid-coated hybrid nanoparticles against bacterial infections.

Authors:  Lai Jiang; Hiang Wee Lee; Say Chye Joachim Loo
Journal:  RSC Adv       Date:  2020-02-27       Impact factor: 4.036

2.  Imidazole-Based pH-Sensitive Convertible Liposomes for Anticancer Drug Delivery.

Authors:  Ruiqi Huang; Vijay Gyanani; Shen Zhao; Yifan Lu; Xin Guo
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.